Re: Addition of Docetaxel, Zoledronic Acid, or Both to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Survival Results from an Adaptive, Multiarm, Multistage, Platform Randomised Controlled Trial.
Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. Electronic address: cora.sternberg@pansadoro.it.
Cora N
CN
Sternberg
D000971:Antineoplastic Combined Chemotherapy Protocols; D004164:Diphosphonates; D000077143:Docetaxel; D006801:Humans; D007093:Imidazoles; D008297:Male; D011471:Prostatic Neoplasms; D043823:Taxoids; D000077211:Zoledronic Acid
D004164:Diphosphonates; D007093:Imidazoles; D043823:Taxoids; D000077143:Docetaxel; D000077211:Zoledronic Acid